Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights

Go back to Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights

JMP Securities Downgrades Foundation Medicine (FMI) to Market Perform

July 30, 2015 6:51 AM EDT

JMP Securities downgraded Foundation Medicine (NASDAQ: FMI) from Market Outperform to Market Perform and removed its price target (prior $57.00).

For an analyst ratings summary and ratings history on Foundation Medicine click here. For more ratings news on Foundation Medicine click here.

Shares of Foundation Medicine closed at $29.30 yesterday.

... More

Foundation Medicine (FMI) Misses Q2 EPS by 45c

July 29, 2015 4:09 PM EDT

Foundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($0.98), $0.45 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $22.5 million versus the consensus estimate of $24.44 million.

Foundation Medicine sees FY2015 revenue of $85-95 million.

Foundation Medicine delivered 16% quarter-over-quarter revenue growth... More